Using brain stimulation to improve navigation skills
Official title: Modulating Spatial Processing During Goal-directed Navigation Using Transcranial Magnetic Stimulation
Run by Rutgers, The State University of New Jersey · NCT05801861 · Data updated 2026-11-12
This study is testing if using brain stimulation can help people improve their navigation skills while they explore virtual environments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 55 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (Newark, New Jersey) |
| Status | Recruiting |
| Started | March 24, 2023 |
| Main results expected | August 31, 2026 |
| Study ends | August 31, 2026 |
| Registry record updated | November 17, 2025 |
| Trial ID | NCT05801861 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults aged 18 to 55 who are stable in mental and physical health.
✕Probably not a fit
Patients with a history of neurological disorders, significant brain lesions, or contraindications to MRI or TMS may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study examines how transcranial magnetic stimulation (TMS) affects spatial processing during goal-directed navigation tasks. Participants will engage in virtual navigation while receiving either active or sham TMS to the parietal cortex, with their brain activity monitored using EEG and MRI. The goal is to determine if modulating brain oscillations can enhance spatial encoding of rewards and influence decision-making during navigation. The study involves a randomized control design with multiple sessions over two weeks.
Why it matters
Potential benefit: If successful, this approach could lead to new therapies for improving navigation skills in individuals with spatial processing deficits.
How similar studies have gone: While the use of TMS in cognitive enhancement is being explored, this specific application to spatial navigation is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Be between the ages of 18 and 55 years old. 2. Not received substance abuse treatment within the previous 30 days. 3. Be in stable mental and physical health. 4. If female, test non-pregnant. 5. No evidence of focal or diffuse brain lesion on MRI. 6. Be willing to provide informed consent. 7. Be able to comply with protocol requirements and likely to complete all study procedures. Exclusion Criteria: 1. Contraindication to MRI (e.g., presence of metal in the skull, orbits or intracranial cavity, claustrophobia). 2. Contraindication to rTMS (history of neurological disorder or seizure, increased intracranial pressure, brain surgery, or head trauma with loss of consciousness for \> 15 minutes, implanted electronic device, metal in the head, or pregnancy). 3. History of autoimmune, endocrine, viral, or vascular disorder affecting the brain. 4. History or MRI evidence of neurological disorder that would lead to local or diffuse brain lesions or significant physical impairment. 5. Life time history of mental disorders such as: Bipolar Affective disorder (BPAD), Schizophrenia, Post-traumatic Stress disorder (PTSD) or Dementia or Major Depression. uninterruptable central nervous system medication.
Where it's running
-
Rutgers University - Newark
Newark, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Travis E Baker — Rutgers University
- Study coordinator: Travis E Baker, PhD
- Email: travis.e.baker@rutgers.edu
- Phone: 973-353-5485
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ctDNA-guided stopping of immune therapy in advanced melanoma
This study tests whether stopping immune checkpoint inhibitor therapy after 12 months is safe for patients with advanced melanoma who have undetectable ctDNA and disease control.
-
Personalized brain-targeted TMS for smoking cessation
A personalized brain-guided Transcranial Magnetic Stimulation (TMS) approach is tested against a standard TMS method to see if it better changes reward brain activity and reduces cravings and smoking in adults with tobacco use disorder.
-
Luminal Bladder Cancer: Testing Neoadjuvant Therapy vs Immediate Surgery in Luminal MIBC
We’re testing whether moving straight to radical cystectomy is safe and effective for patients with luminal muscle-invasive bladder cancer compared to the standard neoadjuvant therapy followed by surgery.
-
Genetics of Blood Cancers in the U.S. population
This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.
-
Sun Safe Together: a digital skin cancer prevention approach for teens and their parents
A small, single-arm trial will test whether a 12-week digital program using teen MMS messages and a private Facebook group for parents can feasibly and acceptably improve sun safety among adolescents and their parents.
-
Exercise and nasal insulin in Type 2 diabetes: does adding insulin spray help the brain more
In older adults with Type 2 diabetes, researchers are testing whether combining regular exercise with an intranasal insulin spray improves brain blood flow and thinking abilities more than exercise with a placebo spray.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.